Evidence map›Paper›PMID 35742896›Full record

ArticleInternational journal of molecular sciences2022

Tinashe P Maviza, Anastasiia S Zarechenskaia, Nadezhda R Burmistrova, Andrey S Tchoub, Olga A Dontsova, Petr V Sergiev, Ilya A Osterman

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Tinashe P MavizaCenter of Life Sciences, Skolkovo Institute of Science and Technology, Moscow 121205, Russia.ORCID 0000-0001-8676-7445
Anastasiia S ZarechenskaiaCenter of Life Sciences, Skolkovo Institute of Science and Technology, Moscow 121205, Russia.
Nadezhda R BurmistrovaDepartment of Chemistry, Faculty of Bioengineering and Bioinformatics and Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow 119992, Russia.
Andrey S TchoubDepartment of Chemistry, Faculty of Bioengineering and Bioinformatics and Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow 119992, Russia.
Olga A DontsovaCenter of Life Sciences, Skolkovo Institute of Science and Technology, Moscow 121205, Russia.
Petr V SergievCenter of Life Sciences, Skolkovo Institute of Science and Technology, Moscow 121205, Russia.
Ilya A OstermanCenter of Life Sciences, Skolkovo Institute of Science and Technology, Moscow 121205, Russia.ORCID 0000-0001-7748-980X
Skolkovo Institute of Science and Technology · RULomonosov Moscow State University · RU

Funding

Russian Science Foundation 20-74-10031
6 · The paper itself

Abstract

In the bid to survive and thrive in an environmental setting, bacterial species constantly interact and compete for resources and space in the microbial ecosystem. Thus, they have adapted to use various antibiotics and toxins to fight their rivals. Simultaneously, they have evolved an ability to withstand weapons that are directed against them. Several bacteria harbor colicinogenic plasmids which encode toxins that impair the translational apparatus. One of them, colicin E3 ribotoxin, mediates cleavage of the 16S rRNA in the decoding center of the ribosome. In order to thrive upon deployment of such ribotoxins, competing bacteria may have evolved counter-conflict mechanisms to prevent their demise. A recent study demonstrated the role of PrfH and the RtcB2 module in rescuing a damaged ribosome and the subsequent re-ligation of the cleaved 16S rRNA by colicin E3 in vitro. The

Indexed as

ColicinsAmino Acyl-tRNA SynthetasesEcosystemEscherichia coliEscherichia coli ProteinsOperonPlasmidsRNA, Ribosomal, 16SAmino Acyl-tRNA SynthetasesColicinsEscherichia coli ProteinsRNA, Ribosomal, 16SRtcB protein, E colibacteriaribosome rescueRNA ligationrRNA cleavagetranslationtranslation termination factor

Identifiers

PMID35742896
PMCPMC9223846
OpenAlexW4281661087

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.